Cargando…
SNAP25 is a potential prognostic biomarker for prostate cancer
BACKGROUND: Prostate cancer (PCa) is one of the most lethal cancers in male individuals. The synaptosome associated protein 25 (SNAP25) gene is a key mediator of multiple biological functions in tumors. However, its significant impact on the prognosis in PCa remains to be elucidated. METHODS: We per...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991690/ https://www.ncbi.nlm.nih.gov/pubmed/35392903 http://dx.doi.org/10.1186/s12935-022-02558-2 |
_version_ | 1784683623699447808 |
---|---|
author | Di, Longjiang Gu, Maoli Wu, Yan Liu, Guoqiang Zhang, Lishuo Li, Yifei Zhang, Wenjing |
author_facet | Di, Longjiang Gu, Maoli Wu, Yan Liu, Guoqiang Zhang, Lishuo Li, Yifei Zhang, Wenjing |
author_sort | Di, Longjiang |
collection | PubMed |
description | BACKGROUND: Prostate cancer (PCa) is one of the most lethal cancers in male individuals. The synaptosome associated protein 25 (SNAP25) gene is a key mediator of multiple biological functions in tumors. However, its significant impact on the prognosis in PCa remains to be elucidated. METHODS: We performed a comprehensive analysis of the Cancer Genome Atlas dataset (TCGA) to identify the differentially expressed genes between PCa and normal prostate tissue. We subjected the differentially expressed genes to gene ontology analysis and Kyoto Encyclopedia of Genes and Genomes functional analysis, and constructed a protein–protein interaction network. We then screened for pivotal genes to identify the hub genes of prognostic significance by performing Cox regression analysis. We identified SNAP25 as one such gene and analyzed the relationship between its expression in PCa to poor prognosis using GEPIA interactive web server. RESULTS: TCGA database demonstrated that SNAP25 was significantly downregulated in PCa. The progressive decrease in SNAP25 expression with the increase in the clinical staging and grading of PCa demonstrates that reduced SNAP25 expression considerably exacerbates the clinical presentation. Our findings confirm that SNAP25 expression strongly correlates with overall survival, which was determined using the Gleason score. We also validated the role of SNAP25 expression in the prognosis of patients with PCa. We used Gene Set Enrichment and Gene Ontology analyses to evaluate the function of SNAP25 and further explored the association between SNAP25 expression and tumor-infiltrating immune cells using the Tumor Immune Assessment Resource database. We found for the first time that SNAP25 is involved in the activation, differentiation, and migration of immune cells in PCa. Its expression was positively correlated with immune cell infiltration, including B cells, CD8(+) T cells, CD4(+) T cells, neutrophils, dendritic cells, macrophages, and natural killer cells. SNAP25 expression also positively correlated with chemokines/chemokine receptors, suggesting that SNAP25 may regulate the migration of immune cells. In addition, our experimental results verified the low expression of SNAP25 in PCa cells. CONCLUSION: Our findings indicate a relationship between SNAP25 expression and PCa, demonstrating that SNAP25 is a potential prognostic biomarker due to its vital role in immune infiltration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02558-2. |
format | Online Article Text |
id | pubmed-8991690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89916902022-04-09 SNAP25 is a potential prognostic biomarker for prostate cancer Di, Longjiang Gu, Maoli Wu, Yan Liu, Guoqiang Zhang, Lishuo Li, Yifei Zhang, Wenjing Cancer Cell Int Primary Research BACKGROUND: Prostate cancer (PCa) is one of the most lethal cancers in male individuals. The synaptosome associated protein 25 (SNAP25) gene is a key mediator of multiple biological functions in tumors. However, its significant impact on the prognosis in PCa remains to be elucidated. METHODS: We performed a comprehensive analysis of the Cancer Genome Atlas dataset (TCGA) to identify the differentially expressed genes between PCa and normal prostate tissue. We subjected the differentially expressed genes to gene ontology analysis and Kyoto Encyclopedia of Genes and Genomes functional analysis, and constructed a protein–protein interaction network. We then screened for pivotal genes to identify the hub genes of prognostic significance by performing Cox regression analysis. We identified SNAP25 as one such gene and analyzed the relationship between its expression in PCa to poor prognosis using GEPIA interactive web server. RESULTS: TCGA database demonstrated that SNAP25 was significantly downregulated in PCa. The progressive decrease in SNAP25 expression with the increase in the clinical staging and grading of PCa demonstrates that reduced SNAP25 expression considerably exacerbates the clinical presentation. Our findings confirm that SNAP25 expression strongly correlates with overall survival, which was determined using the Gleason score. We also validated the role of SNAP25 expression in the prognosis of patients with PCa. We used Gene Set Enrichment and Gene Ontology analyses to evaluate the function of SNAP25 and further explored the association between SNAP25 expression and tumor-infiltrating immune cells using the Tumor Immune Assessment Resource database. We found for the first time that SNAP25 is involved in the activation, differentiation, and migration of immune cells in PCa. Its expression was positively correlated with immune cell infiltration, including B cells, CD8(+) T cells, CD4(+) T cells, neutrophils, dendritic cells, macrophages, and natural killer cells. SNAP25 expression also positively correlated with chemokines/chemokine receptors, suggesting that SNAP25 may regulate the migration of immune cells. In addition, our experimental results verified the low expression of SNAP25 in PCa cells. CONCLUSION: Our findings indicate a relationship between SNAP25 expression and PCa, demonstrating that SNAP25 is a potential prognostic biomarker due to its vital role in immune infiltration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02558-2. BioMed Central 2022-04-07 /pmc/articles/PMC8991690/ /pubmed/35392903 http://dx.doi.org/10.1186/s12935-022-02558-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Di, Longjiang Gu, Maoli Wu, Yan Liu, Guoqiang Zhang, Lishuo Li, Yifei Zhang, Wenjing SNAP25 is a potential prognostic biomarker for prostate cancer |
title | SNAP25 is a potential prognostic biomarker for prostate cancer |
title_full | SNAP25 is a potential prognostic biomarker for prostate cancer |
title_fullStr | SNAP25 is a potential prognostic biomarker for prostate cancer |
title_full_unstemmed | SNAP25 is a potential prognostic biomarker for prostate cancer |
title_short | SNAP25 is a potential prognostic biomarker for prostate cancer |
title_sort | snap25 is a potential prognostic biomarker for prostate cancer |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991690/ https://www.ncbi.nlm.nih.gov/pubmed/35392903 http://dx.doi.org/10.1186/s12935-022-02558-2 |
work_keys_str_mv | AT dilongjiang snap25isapotentialprognosticbiomarkerforprostatecancer AT gumaoli snap25isapotentialprognosticbiomarkerforprostatecancer AT wuyan snap25isapotentialprognosticbiomarkerforprostatecancer AT liuguoqiang snap25isapotentialprognosticbiomarkerforprostatecancer AT zhanglishuo snap25isapotentialprognosticbiomarkerforprostatecancer AT liyifei snap25isapotentialprognosticbiomarkerforprostatecancer AT zhangwenjing snap25isapotentialprognosticbiomarkerforprostatecancer |